Talking Pictures Social Media Intervention in Reducing Depressive Symptoms and Improving Spiritual Well-Being and Quality of Life in Adolescent and Young Adult Cancer Patients

Talking Pictures: An Exploratory Study of a Meaning-Based Social Media Intervention for AYA Cancer Patients

This clinical trial studies how well Talking Pictures social media intervention works in reducing depressive symptoms and improving spiritual well-being and quality of life in adolescent and young adult cancer patients. Talking Pictures social media intervention may help doctors better learn how to most effectively provide psychosocial support to adolescent and young adult cancer patients.

Study Overview

• Status: Completed
• Conditions: Malignant Neoplasm
• Intervention / Treatment: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Other: Internet-Based Intervention

Detailed Description

PRIMARY OBJECTIVES:

I. To determine the feasibility and acceptability of a 10-week application (app)-based intervention.

II. To assess the impact of the intervention on depressive symptoms, spiritual well-being and quality of life.

III. To examine the content of participants recorded narratives for salient themes related to weekly content areas (e.g. identity, meaning-making, hopes, fears) in order to better understand the unique experiences and challenges of adolescent and young adult (AYA) patients.

OUTLINE:

Participants undergo Talking Pictures social media intervention for 10 weeks, receiving weekly assignments via email with requirements to use the Pixstori app to take and upload photographs with verbal narratives attached to a website. Participants can then share their pixstories to a group page and view and respond to others' pixstories.

After completion of study, participants are followed up at 2 months.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New York
    • Buffalo, New York, United States, 14263
      • Roswell Park Cancer Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 15 years to 34 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adolescent and young adult cancer patients who were diagnosed within three years
• English comprehension in written and oral format
• Current possession of a smartphone, tablet, or computer with camera and wifi capacity or data plan
• Valid email address
• Pregnant women will be included if they meet eligibility requirements

Exclusion Criteria:

• Diagnosis of mental retardation, severe or untreated psychopathology (e.g. schizophrenia), or dementia
• Adults unable to consent: Will not include
• Prisoners will not be included given lack of access to smartphone

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Supportive Care (social media intervention); Participants undergo Talking Pictures social media intervention for 10 weeks, receiving weekly assignments via email with requirements to use the Pixstori app to take and upload photographs with verbal narratives attached to a website. Participants can then share their pixstories to a group page and view and respond to others' pixstories.	Other: Quality-of-Life Assessment; Ancillary studies; Other Names: Quality of Life Assessment; Other: Questionnaire Administration; Ancillary studies; Other: Internet-Based Intervention; Undergo Talking Pictures social media intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Weekly photo task completion rate	The observed completion rate will be described using the binomial completion proportion and its 2-sided 95% Jeffries confidence interval.	At 10 weeks
Project participation rates	Study will be deemed feasible it least 11 of 30 participants demonstrate completion of assignments	At 10 weeks
Impact of intervention on depressive symptoms as assessed by Beck Depression Inventory-II (BDI-II) total score	A series of repeated questionnaires will be conducted.	Up to 2 months post intervention
Impact of intervention on spiritual well-being as assessed by Functional Assessment of Chronic Illness Therapy Spiritual Well-Being (FACIT-Sp) total score	A series of repeated questionnaires will be conducted.	Up to 2 months post intervention
Impact of intervention on psychosocial quality of life as assessed by Pediatric Quality of Life Inventory-Adolescent and Young Adult (PedsQL-AYA) psychosocial health score	A series of questionnaires will be conducted.	Up to 2 months post intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant satisfaction rating	Satisfaction Questionnaire to be conducted	At 10 weeks

Collaborators and Investigators

• Sponsor: Roswell Park Cancer Institute
• Investigators: Principal Investigator: Megan Pailler, Roswell Park Cancer Institute

Study record dates

Study Major Dates

• Study Start (Actual): May 31, 2017
• Primary Completion (Actual): August 13, 2018
• Study Completion (Actual): August 13, 2018

Study Registration Dates

• First Submitted: September 18, 2018
• First Submitted That Met QC Criteria: September 19, 2018
• First Posted (Actual): September 20, 2018

Study Record Updates

• Last Update Posted (Actual): July 25, 2022
• Last Update Submitted That Met QC Criteria: July 20, 2022
• Last Verified: July 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: i 44717 (Other Identifier: Roswell Park Cancer Institute); NCI-2018-00023 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No